Early ablation leads to better outcome in patients < 55 years with persistent atrial fibrillation

被引:2
作者
Erhard, Nico [1 ]
Bahlke, Fabian [1 ]
Neuner, Bruno [2 ]
Popa, Miruna [1 ]
Krafft, Hannah [1 ]
Tunsch-Martinez, Alexander [1 ]
Syvaeri, Jan [1 ]
Tydecks, Madeleine [1 ]
Abdiu, Edison [1 ]
Telishevska, Marta [1 ]
Lengauer, Sarah [1 ]
Hessling, Gabriele [1 ]
Deisenhofer, Isabel [1 ]
Englert, Florian [1 ]
机构
[1] Tech Univ Munich, German Heart Ctr Munich, Dept Electrophysiol, Lazarettstr 36, D-80636 Munich, Germany
[2] Charite Univ Med Berlin, Dept Anesthesiol & Intens Care Med, Berlin, Germany
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
Persistent atrial fibrillation; Diagnosis-to-ablation time; Catheter ablation; Young patients; PULMONARY VEIN ISOLATION; CATHETER ABLATION; EFFICACY; SAFETY; RISK;
D O I
10.1038/s41598-024-76098-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The question of optimal timing for catheter ablation of atrial fibrillation (AF) to achieve best outcomes remains a crucial clinical issue. As AF occurs less frequently in younger patients, data regarding Diagnosis-to-Ablation Time (DAT) is especially limited in patients under the age of 55 years with persistent AF. We therefore analyzed the temporal relationship between initial AF presentation and timing of catheter ablation in this cohort. We conducted a retrospective single-centre study of patients <= 55 years with persistent AF who underwent first-time catheter ablation at our center. The cohort was divided into patients that underwent catheter ablation after diagnosis of persistent AF within a DAT of <= 12 months and patients with a DAT of > 12 months. A total of 101 patients (median age 51 years; female n = 19 (18.8%)) with persistent AF were included. Ablation was performed within 12 months ("early DAT") in 51 patients and > 12 months ("late DAT") in 50 patients. Pulmonary vein isolation was performed using high-power short-duration (HPSD) radiofrequency ablation. Median DAT was 5 months (1-12 months) in the early ablation group and 36 months (13-240 months) in the late ablation group. The median follow-up was 11.3 months (0.03-37.1 months). The rate of any atrial arrhythmia recurrence after a 30-day blanking period was significantly lower in the early DAT group (13/51 patients; 25.5%) as compared to the late DAT group (26/50 patients; 52.0%) (log rank test; p = 0.003). Catheter ablation performed > 12 months after the initial AF diagnosis was an independent predictor for the occurrence of any atrial arrythmia (OR: 2.58; (95%-CI: 1.32-5.07). Early first-time catheter ablation (DAT <= 12 months) in patients <= 55 years with persistent AF is associated with a significantly lower rate of arrhythmia recurrence.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Progression of Atrial Fibrillation after Cryoablation or Drug Therapy [J].
Andrade, J. G. ;
Deyell, M. W. ;
Macle, L. ;
Wells, G. A. ;
Bennett, M. ;
Essebag, V ;
Roux, J-F ;
Yung, D. ;
Skanes, A. ;
Khaykin, Y. ;
Morillo, C. ;
Jolly, U. ;
Novak, P. ;
Lockwood, E. ;
Amit, G. ;
Angaran, P. ;
Sapp, J. ;
Wardell, S. ;
Lauck, S. ;
Cadrin-Tourigny, J. ;
Kochhaeuser, S. ;
Verma, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02) :105-116
[2]   Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial [J].
Andrade, Jason G. ;
Deyell, Marc W. ;
Khairy, Paul ;
Champagne, Jean ;
Leong-Sit, Peter ;
Novak, Paul ;
Sterns, Lawrence ;
Roux, Jean-Francois ;
Sapp, John ;
Bennett, Richard ;
Bennett, Matthew ;
Hawkins, Nathaniel ;
Sanders, Prashanthan ;
Macle, Laurent .
EUROPEAN HEART JOURNAL, 2024, 45 (07) :510-518
[3]   Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation [J].
Andrade, Jason G. ;
Wells, George A. ;
Deyell, Marc W. ;
Bennett, Matthew ;
Essebag, Vidal ;
Champagne, Jean ;
Roux, Jean-Francois ;
Yung, Derek ;
Skanes, Allan ;
Khaykin, Yaariv ;
Morillo, Carlos ;
Jolly, Umjeet ;
Novak, Paul ;
Lockwood, Evan ;
Amit, Guy ;
Angaran, Paul ;
Sapp, John ;
Wardell, Stephan ;
Lauck, Sandra ;
Macle, Laurent ;
Verma, Atul .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04) :305-315
[4]   High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics [J].
Bourier, Felix ;
Duchateau, Josselin ;
Vlachos, Konstantinos ;
Lam, Anna ;
Martin, Claire A. ;
Takigawa, Masateru ;
Kitamura, Takeshi ;
Frontera, Antonio ;
Cheniti, Ghassen ;
Pambrun, Thomas ;
Klotz, Nicolas ;
Denis, Arnaud ;
Derval, Nicolas ;
Cochet, Hubert ;
Sacher, Frederic ;
Hocini, Meleze ;
Haissaguerre, Michel ;
Jais, Pierre .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (11) :1570-1575
[5]   Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes [J].
Bunch, T. Jared ;
May, Heidi T. ;
Bair, Tami L. ;
Johnson, David L. ;
Weiss, J. Peter ;
Crandall, Brian G. ;
Osborn, Jeffrey S. ;
Anderson, Jeffrey L. ;
Muhlestein, J. Brent ;
Lappe, Donald L. ;
Day, John D. .
HEART RHYTHM, 2013, 10 (09) :1257-1262
[6]   Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation A Systematic Review and Meta-Analysis of Observational Studies [J].
Chew, Derek S. ;
Black-Maier, Eric ;
Loring, Zak ;
Noseworthy, Peter A. ;
Packer, Douglas L. ;
Exner, Derek V. ;
Mark, Daniel B. ;
Piccini, Jonathan P. .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2020, 13 (04) :E008128
[7]   Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry [J].
Ding, Wern Yew ;
Calvert, Peter ;
Gupta, Dhiraj ;
Huisman, Menno, V ;
Lip, Gregory Y. H. .
CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (09) :1057-1068
[8]   PREVALENCE, AGE DISTRIBUTION, AND GENDER OF PATIENTS WITH ATRIAL-FIBRILLATION - ANALYSIS AND IMPLICATIONS [J].
FEINBERG, WM ;
BLACKSHEAR, JL ;
LAUPACIS, A ;
KRONMAL, R ;
HART, RG .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) :469-473
[9]   Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Phillips, KA ;
Chang, YC ;
Henault, LE ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375
[10]  
Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945